Zenovel Experience
Designing Future Roads with Proven Expertise and Experience
Designing Future Roads with Proven Expertise and Experience
Over the years of varied experience and successfully completed numerous projects and clinical trials, Zenovel has flourished through reliable, high-quality services grounded in industry expertise.
Zenovel is a global leader in providing comprehensive GCP services, ensuring compliance, data integrity, and quality in clinical trials and research activities. Our experienced team comprises 25+ full-time experts and 450+ contractual auditors/monitors worldwide.
Zenovel’s team is proficient in managing preclinical and clinical research services, ensuring GCP and GLP compliance.
Zenovel’s GMP services showcase our industry-leading expertise and deep-rooted experience. Our team’s collective proficiency spans a variety of facility audits and support activities, including
Our extensive experience with over 150 global clients, including top generic Pharmaceutical Plant, demonstrates our commitment to providing exceptional supply chain support and GMP compliance.
The regulatory team at Zenovel has extensive experience in compiling, reviewing, and submitting dossiers, with key points to emphasize
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.